PUBBLICAZIONI SCIENTIFICHE
ORCID: 0000-0001-5425-0652
SCOPUS ID: 57837569300
WoS: LWI-7829-2024
1. Ometti M, Schipani D, Conte P, Pironti P, Salini V. The efficacy of intra-articular HYADD4-G injection in the treatment of femoroacetabular impingement: results at one year follow up. J Drug Assess. 2020 Nov 17;9(1):159-166. doi: 10.1080/21556660.2020.1843860. PMID: 33235816; PMCID: PMC7671711
2. Conte P, Adravanti FM, Gaggia GMMC, Matteo BD, Marcacci M. Anterior Cruciate Ligament Agenesia in a Patient with Ehlers-Danlos Syndrome and Open Physes. J Orthop Case Rep. 2022 Jan;12(1):26-30. doi: 10.13107/jocr.2022.v12.i01.2602. PMID: 35611276; PMCID: PMC9091396
3. Anzillotti G, Conte P, Di Matteo B, Bertolino EM, Marcacci M, Kon E. Injection of biologic agents for treating severe knee osteoarthritis: is there a chance for a good outcome? A systematic review of clinical evidence. Eur Rev Med Pharmacol Sci. 2022 Aug;26(15):5447-5459. doi: 10.26355/eurrev_202208_29413. PMID: 35993640.
4. Conte P , Anzillotti G , Di Matteo B, Gallese A, Vitale U , Marcacci M, Kon E, Orthobiologic injections for treating degenerative meniscus lesions: a matter of facts? Ten years of clinical experience in a systematic review, Journal of Cartilage & Joint Preservation (2023), doi: 10.1016/j.jcjp.2023.100104
5. Vandenbulcke F, Anzillotti G, Ravasio G, Malagoli E, Conte P, Balzarini B, Kirienko A, Kon E. External fixator-assisted plating osteosynthesis in a rabbit model of femoral bone defects appears to be a feasible and reproducible surgical technique: preliminary insights from a bone substitute study. J Exp Orthop. 2023 Aug 1;10(1):77. doi: 10.1186/s40634-023-00644-6. PMID: 37526773; PMCID: PMC10393914.
6. Anzillotti G, Guazzoni E, Conte P, Di Matteo V, Kon E, Grappiolo G, Loppini M. Using Three-Dimensional Printing Technology to Solve Complex Primary Total Hip Arthroplasty Cases: Do We Really Need Custom-Made Guides and Templates? A Critical Systematic Review on the Available Evidence. J Clin Med. 2024 Jan 15;13(2):474. doi: 10.3390/jcm13020474. PMID: 38256607.
7. Anzillotti G, Öttl FC, Franceschi C, Conte P, Bertolino EM, Lipina M, Lychagin A, Kon E, Di Matteo B. No Significant Differences between Bisphosphonates and Placebo for the Treatment of Bone Marrow Lesions of the Knee: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2024 Jun 28;13(13):3799. doi: 10.3390/jcm13133799. PMID: 38999364; PMCID: PMC11242668.
8. Di Matteo B, Anzillotti G, Conte P, Angele P, Emans P, Minguell-Monyart J, Woodell-May J, Correa-Tapia M, Kon E. Subchondroplasty® (SCP) Provides Resolution of Symptoms and Functional Improvements in Mild-to-Moderate Knee Osteoarthritis with Persistent Bone Marrow Lesions: 12-Month Follow-Up Results from a Multicentric Open-Label Prospective Clinical Trial. Cartilage. 2024 Jul 30:19476035241264011. doi: 10.1177/19476035241264011. Epub ahead of print. PMID: 39076070.
9. Kon E, Anzillotti G, Conte P, Ruosi L, Cole B, Dragoo J, Zaslav K, Frank R, De Girolamo L, Mandelbaum B, Rodeo S, Marcacci M, Filardo G, Di Matteo B. The chimera of reaching a universal consensus on platelet-rich plasma treatment for knee osteoarthritis: a review of recent consensus statements and expert opinion. Expert Opin Biol Ther. 2024 Aug 2:1-7. doi: 10.1080/14712598.2024.2383865. Epub ahead of print. PMID: 39073848.
10. Conte P, Anzillotti G, Crawford DC, Dasa V, Flanigan DC, Nordt WE, Scopp JM, Meislin RJ, Strauss EJ, Strickland SM, Fiorentino G, Lattermann C. Differential analysis of the impact of lesions' location on clinical and radiological outcomes after the implantation of a novel aragonite-based scaffold to treat knee cartilage defects. Int Orthop. 2024 Sep 21. doi: 10.1007/s00264-024-06314-1. Epub ahead of print. PMID: 39305313.
11. Bonanzinga T, Conte P, Anzillotti G, Longobardi V, Kon E, Rescigno M, Marcacci M. Native intra-articular knee microbiome is a matter of facts: a systematic review of clinical evidence. EFORT Open Rev. 2024 Oct 3;9(10):969-979. doi: 10.1530/EOR-23-0191. PMID: 39360783.
12. Hinckel BB, Conte P, Smith JT, Nakamura N, Kon E. Patellofemoral Instability Part 3 (Patellofemoral Cartilage Treatment): State Of The Art. J ISAKOS. 2024 Nov 21:100366. doi: 10.1016/j.jisako.2024.100366. Epub ahead of print. PMID: 39580146.
13. Anzillotti G, Gomoll AH, Conte P, Bulgarelli A, Queirazza P, Marcacci M, Kon E, Di Matteo B. Limited evidence for the usage of renin-angiotensin-aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence. J Exp Orthop. 2024 Dec 11;11(4):e70089. doi: 10.1002/jeo2.70089. PMID: 39664927; PMCID: PMC11633675.
14. Perelli S, Conte P, Pizza N, Morales-Avalos R, Kon E, Grassi A, Zaffagnini S, Monllau JC. Meniscal extrusion: Proposal for a novel qualitative classification. J Exp Orthop. 2024 Dec 31;12(1):e70126. doi: 10.1002/jeo2.70126. PMID: 39741910; PMCID: PMC11685843.
15. Bulgarelli A, Ruosi L, Conte P, Anzillotti G, Di Matteo B, Kon E. Matrices Used for Cartilage Regeneration, Clin Sports Med. 2025 Jan; doi.org/10.1016/j.csm.2024.12.003
16. Conte P, Anzillotti G, Pizza N, Chiappe C, Morales-Avalos R, Sanchis-Alfonso V, Monllau JC, Perelli S. Radiological assessment of lower limb torsional deformities: a narrative review. Ann Jt. 2025 Jan 21;10:7. doi: 10.21037/aoj-24-42. PMID: 39981433; PMCID: PMC11836740.
17. Kon E, Conte P, Anzillotti G, Di Matteo B, Verdonk P. Report on Evolving Indications, Techniques, and Outcome of Novel and Innovative Surgical procedure - Agili C®. Curr Rev Musculoskelet Med. 2025 Feb 14. doi: 10.1007/s12178-025-09951-0. Epub ahead of print. PMID: 39951240.
18. Chiari Gaggia GMM, Conte P, Anzillotti G, Lipina M, Di Matteo B, Kon E, Platelet-Based Injections for Knee Osteoarthritis: Do They Work, Are They Safe?, Clinics in Sports Medicine, March 2025, doi: 10.1016/j.csm.2024.10.009
19. Vandenbulcke, F.; Renne, S.L.; Anzillotti, G.; Conte, P.; Ravasio, G.; Meroni, G.; Riva, F.; Kon, E. “Anti-Bios”: Can Local Antibiotics Affect Bone Union in Infected Bone Defects Treated with Degradable Bone Substitutes. Biomedicines 2025, 13, 1070. https://doi.org/10.3390/biomedicines13051070
20. Vacca M, Ruosi L, Chiari-Gaggia GMM Balzarini B, Anzillotti G, Conte P, Di Matteo B, Kon E, Altomare D, Ultrasound-Guided Meniscal Injection of Autologous Conditioned Plasma: a case series at middle term evaluation, Journal of Cartilage & Joint Preservation, 2025, 100242, ISSN 2667-2545, doi:10.1016/j.jcjp.2025.100242.
21. Pizza N, Conte P, Concha M, Simón-Sánchez FJ, Ibañez M, Claramunt RT, Sartidis A, Hantes M, Perelli S, Monllau JC. Good results with low failure rate and high patients' satisfaction after selective bundle anterior cruciate ligament (ACL) reconstruction for partial tears at average 14-years follow-up. Knee. 2025 May 9;55:161-167. doi: 10.1016/j.knee.2025.04.015. Epub ahead of print. PMID: 40347697.
22. Anzillotti G, Conte P, Bertolino EM, Ferrero A, Di Matteo B, Vacca M, Di Martino M, Altomare D, Magarelli N, Lanza E, Verdonk P, Kon E. Intra- and peri-meniscal polynucleotide injections for the treatment of symptomatic degenerative meniscus of the knee: 1-year findings from a prospective clinical trial. Eur Rev Med Pharmacol Sci. 2025 Jun;29(6):313-323. doi: 10.26355/eurrev_202506_37273. PMID: 40613622.
23. Timmerman A, Denayer T, Conte P, Vanermen F, Verdonk P. Neuroma of the infrapatellar branch of the saphenous nerve: surgical treatment technique and outcome. Acta Orthop Belg. 2025 Mar;91(1):117-123. doi: 10.52628/91.1.14101. PMID: 40803307..
24. Hendrikx FR, Conte P, Van Haver A, Vuylsteke K, Lagae KC, Verdonk P. Smokers present a three times higher risk of graft failure after ACL reconstruction: a single-center retrospective analysis. J Exp Orthop. 2025; 12:e70422. https://doi.org/10.1002/jeo2.70422
25. Elphingstone J, Bowler M, Conte P, Anzillotti G, Kon E. The promising potential of polynucleotide injections for knee osteoarthritis: a systematic review of literature and meta-analysis of randomized control trials. J Exp Orthop. 2025; 12:e70428. https://doi.org/10.1002/jeo2.70428
26. de Caro F, Conte P, Vuylsteke K, Simonini C, Verdonk P. Satisfactory survivorship and clinical outcomes up to 10 years after the implantation of a novel personalized metal implant for the treatment of osteochondral lesions of the knee. J ISAKOS. 2025 Oct 9:101013. doi: 10.1016/j.jisako.2025.101013. Epub ahead of print. PMID: 41076193.
27. Di Matteo B, Franceschi C, Anzillotti G, Conte P, D'Arrigo D, Lipina M, Lychagin A, Kalinsky E, Verdonk R, Kon E. Review of Brittberg's article on the treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation: "The Classic". J ISAKOS. 2025 Oct 13:101020. doi: 10.1016/j.jisako.2025.101020. Epub ahead of print. PMID: 41093183.
28. Anzillotti G, Vespasiano F, Öttl F, Conte P, Minelli M, Raspugli GF, Svensson Di Giorgio S, Valente R, Kon E, Di Matteo B. Statins: bitter enemies of tendons or not? A systematic review of clinical evidence. Eur Rev Med Pharmacol Sci. 2025 Oct;29(10):457-469. doi: 10.26355/eurrev_202510_37466. PMID: 41182304.
29. Anzillotti G, Pavone S, Queirazza P, Conte P, Saccia F, Minelli M, Petrov P, Kon E, Di Matteo B. Knee Joint Distraction and Implantable Shock Absorbers for Knee Osteoarthritis: A Systematic Review of Joint-Preserving Outcomes, Structural Changes, and Complications. Cartilage. 2026 Jan 30:19476035251409412. doi: 10.1177/19476035251409412. Epub ahead of print. PMID: 41618156; PMCID: PMC12861414.
30. Abu Salem Y, Franceschi C, Alberto G, Conte P, Anzillotti G, D’Arrigo D, Di Matteo B, Kon, Can we treat meniscal tears with injectables? A systematic review of clinical outcomes following platelet-rich plasma, corticosteroid, and other injective therapies for degenerative and traumatic meniscal lesions, 2026 Feb 23, Journal of Cartilage & Joint Preservation, doi: 10.1016/j.jcjp.2026.100284i
31. Franceschi C, Tasso F, Simili V, Monteleone G, Martorelli F, De Angelis A, Cialdella E, Esposito D, Anzillotti G, Conte P, Di Matteo B, Kon E, Scardino M. Chloroprocaine vs. prilocaine for spinal anesthesia in outpatient knee arthroscopy: a prospective economic evaluation using activity-based costing. Eur Rev Med Pharmacol Sci. 2026 Feb;30(2):83-90. doi: 10.26355/eurrev_202602_37690. PMID: 41773612.